Mauro Bove
Direktor/Vorstandsmitglied bei REGENERX BIOPHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| J. Finkelstein | M | 72 | 40 Jahre | |
| Allan L. Goldstein | M | 86 | 42 Jahre | |
| Achim Josef Müller | M | - |
EyeSense AG
 EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | 18 Jahre |
| Olav Bergheim | M | 74 |
Kato Pharmaceuticals, Inc.
 Kato Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kato Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. The firm engages in the development of therapies for pathologies of the eye. It focuses on disease progression and diabetic retinopathy. The company was founded by Olav B. Bergheim and Terrance S. McGovern and is headquartered in Laguna Hills, CA. | - |
| Xiao Yi Li | M | 62 | 7 Jahre | |
| Alessandro Noseda | M | 66 | 5 Jahre | |
| Lit-Fui Lau | M | 62 | 8 Jahre | |
| Lok Yee Li | M | 45 | - | |
| Joe McNay | M | 90 | 22 Jahre | |
| Suk Yan Yau | F | 42 | 5 Jahre | |
| Fui Kiang Liew | M | 57 | 2 Jahre | |
| Xiangrong Dai | M | 45 | 8 Jahre | |
| Yuk Lam Lo | M | 76 | 3 Jahre | |
| Yiu Ming Chow | M | 50 | 10 Jahre | |
| Hin Wing Wong | M | 62 | 3 Jahre | |
| R. Elsey | M | 71 | 14 Jahre | |
| Lei Yin | M | 51 | 10 Jahre | |
| Albert Tsai | M | 51 | 3 Jahre | |
| Jiang Feng | M | 49 | 4 Jahre | |
| Carol Liu | F | 41 | 3 Jahre | |
| Su Jiang | M | 44 | 6 Jahre | |
| Lei Yang | F | 44 | 3 Jahre | |
| Tiantian Zhang | F | 42 | 3 Jahre | |
| Katharina Schmid | M | - |
EyeSense AG
EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | - |
| Xin Yan Feng | F | 47 | 4 Jahre | |
| Moller Thomas | M | - |
EyeSense AG
EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | - |
| Gosch Torsten | M | - |
EyeSense AG
EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | - |
| Surasak Lelalertsuphakun | M | 40 | 9 Jahre | |
| Michael J. Tillman | M | - |
EyeSense AG
EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | - |
| Wanee Leelalertsuphakun | F | 71 | 7 Jahre | |
| Willi Hörner | M | - |
EyeSense AG
EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | - |
| Terrance McGovern | M | - |
Kato Pharmaceuticals, Inc.
Kato Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kato Pharmaceuticals, Inc. operates as a bio-pharmaceutical company. The firm engages in the development of therapies for pathologies of the eye. It focuses on disease progression and diabetic retinopathy. The company was founded by Olav B. Bergheim and Terrance S. McGovern and is headquartered in Laguna Hills, CA. | - |
| Thomas Möller | M | 54 |
EyeSense AG
EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | - |
| Luzi Andreas von Bidder | M | 71 |
EyeSense AG
EyeSense AG Medical SpecialtiesHealth Technology EyeSense AG develops novel continuous blood glucose monitoring systems for diabetes patients. The firm's continuous glucose monitoring (CGM) gives a sense of security to diabetic patients. The company was founded by Achim Müller in 2006 and is headquartered in Basel, Switzerland. | - |
| Victor Kailok Tsui | M | - | 12 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| C. Neil Lyons | M | 66 | 6 Jahre | |
| David R. Crockford | M | 79 | - | |
| L. Thompson Bowles | M | 92 | 8 Jahre | |
| Richard J. Hindin | M | 81 | 8 Jahre | |
| Marco Brughera | M | 70 |
Essetifin SpA
 Essetifin SpA Pharmaceuticals: MajorHealth Technology Essetifin SpA operates as a holding company. The company was founded in 1957 and is headquartered in Rome, Italy. | 3 Jahre |
| Marco Codella | M | 64 |
Essetifin SpA
Essetifin SpA Pharmaceuticals: MajorHealth Technology Essetifin SpA operates as a holding company. The company was founded in 1957 and is headquartered in Rome, Italy. | 6 Jahre |
| Yee Ha Luen | F | - | 9 Jahre | |
| Lai Fan Tam | M | 67 | - | |
| Simon Miles Ball | M | 45 | 4 Jahre | |
| Diego Provvedini | M | - |
University of Parma
| 3 Jahre |
| Konstantinos Papadopoulos | M | 72 |
University of Parma
| 4 Jahre |
| Carlo Scarpa | M | - |
University of Parma
| 5 Jahre |
| Eugenio Brianti | M | 70 |
University of Parma
| 3 Jahre |
| Giuseppe Bianchi | M | - | - | |
| Francesco Ceci | M | - |
University of Parma
| 5 Jahre |
| Yu Chen | M | 43 | 4 Jahre | |
| Li Cai | F | 40 | 3 Jahre | |
| William Giroldini | M | - |
University of Parma
| 3 Jahre |
| Marco Livelli | M | 65 |
University of Parma
| 4 Jahre |
| Federico Ghizzoni | M | 68 |
University of Parma
| 3 Jahre |
| Angelo Busani | M | 63 |
University of Parma
| 3 Jahre |
| Alan Klein | M | - | - | |
| Nabila Turjman | M | - | - | |
| Alberto Chiesi | M | 85 |
University of Parma
| 4 Jahre |
| Enrico Corradi | M | 67 |
University of Parma
| 4 Jahre |
| Zuie Chin Huang | M | 58 | - | |
| Alberto Bartoli | M | 63 |
University of Parma
| 4 Jahre |
| Dane Saglio | M | 66 | 3 Jahre | |
| Gregg Lapointe | M | 65 |
Essetifin SpA
Essetifin SpA Pharmaceuticals: MajorHealth Technology Essetifin SpA operates as a holding company. The company was founded in 1957 and is headquartered in Rome, Italy. | 4 Jahre |
| Francesco Landriscina | M | 64 |
University of Parma
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| China | 20 | 30,77% |
| Italien | 16 | 24,62% |
| Vereinigte Staaten | 14 | 21,54% |
| Hong Kong | 10 | 15,38% |
| Schweiz | 8 | 12,31% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mauro Bove
- Persönliches Netzwerk
